, Volume 45, Issue 5–6, pp 448–452 | Cite as

Antinociceptive Effects of Valeriana Extract in Mice: Involvement of the Dopaminergic and Serotonergic Systems

  • S. Shahidi
  • A. Bathaei
  • P. Pahlevani

Valeriana officinalis has been extensively used as a herbal remedy in traditional medicine. However, there is no clear evidence on the antinociceptive effects of this plant. The aim of our study was to evaluate the effect of Valeriana officinalis hydroalcoholic extract on pain modulation and its possible mechanism in mice. Adult male Balb/c mice were randomly divided into nine experimental groups. They received i.p. injections of saline, hydroalcoholic root extract of Valeriana officinalis (800, 200, or 50 mg/kg), and morphine; four groups received Valeriana (800 mg/kg) + antagonists of the systems involved in antinociception effects, naloxone, ondansetron, metoclopramide, or scopolamine. Tail-flick and writhing tests were used for estimation of possible modulation of pain. The tail-flick latencies in the Valeriana 800 and 200 mg/kg, but not 50 mg/kg, morphine, and combined Valeriana 800 + + naloxone, ondansetron, metoclopramide, or scopolamine-treated groups were significantly longer than that in the control group. However, the tail-flick latencies in the Valeriana 800 mg/kg + ondansetronand metoclopramide-treated groups were significantly shorter than that upon single action of the extract (800 mg/kg). The numbers of writhings in the extract-treated groups were smaller than in the control one. The numbers of writhings in the Valeriana (800 mg/kg) + ondansetron- and metoclopramidetreated groups were significantly greater than in the extract (800 mg/kg) group. It is concluded that Valeriana officinalis extract possesses a clear analgesic effect and works through the serotonergic and dopaminergic systems.


Valeriana officinalis tail-flick test writhing test flavonoids pain mice 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. B. Calixto, A. Beirith, J. Ferreira, et al. , “Naturally occurring antinociceptive substances from plants,” Phytother. Res., 14, No. 6, 401-418 (2000).PubMedCrossRefGoogle Scholar
  2. 2.
    M. A. O’Hara, D. Kiefer, K. Farrell, and K. Kemper, “A review of 12 commonly used medicinal herbs,” Arch. Fam. Med., 7, No. 6, 523-536 (1998).PubMedCrossRefGoogle Scholar
  3. 3.
    C. S. Yuan, S. Mehendale, Y. Xiao, et al., “The gammaaminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity,” Anesth. Analg., 98, No. 2, 353-358 (2004).PubMedCrossRefGoogle Scholar
  4. 4.
    C. Stevinson and E. Ernst, “Valerian for insomnia: a systematic review of randomized clinical trials,” Sleep Med., 1, No. 2, 91-99 (2000).PubMedCrossRefGoogle Scholar
  5. 5.
    L. M. Del Valle-Mojica, J. M. Cordero-Hernández, G. González-Medina, et al., “Aqueous and ethanolic Valeriana officinalis extracts change the binding of ligands to glutamate receptors,” Evid.-Based Complement. Alternat. Med., Article ID 891819, 7 pages (2011).Google Scholar
  6. 6.
    S. Hadley and J. J. Petry, “Valerian,” Am. Fam. Physician, 67, No. 8, 1755-1758 (2003).PubMedGoogle Scholar
  7. 7.
    J. O. Malva, S. Santos, and T. Macedo, “Neuroprotective properties of Valeriana officinalis extracts,” Neurotox. Res., 6, No. 2, 131-140 (2004).PubMedCrossRefGoogle Scholar
  8. 8.
    A. Diaper and I. Hindmarch, “A double-blind, placebocontrolled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor functions of sleep-disturbed older adults,” Phytother. Res., 18, No. 10, 831-836 (2004).PubMedCrossRefGoogle Scholar
  9. 9.
    S. Bent, A. Padula, D. Moore, et al., “Valerian for sleep: a systematic review and meta-analysis,” Am. J. Med., 119, No. 12, 1005-1012 (2006).PubMedCrossRefGoogle Scholar
  10. 10.
    R. Fachinetto, J. G. Villarinho, C. Wagner, et al., “Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter,” Prog. Neuropsychopharmacol. Biol. Psychiat., 31, No. 7, 1478-1486 (2007).CrossRefGoogle Scholar
  11. 11.
    M. Marder, H. Viola, C. Wasowski, et al., “6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS,” Pharmacol. Biochem. Behav., 75, No. 3, 537-545 (2003).PubMedCrossRefGoogle Scholar
  12. 12.
    P. J. Houghton, “The scientific basis for the reputed activity of Valerian,” J. Pharm. Pharmacol., 51, No. 5, 505-512 (1999).PubMedCrossRefGoogle Scholar
  13. 13.
    E. M. Choi, “Antinociceptive and antiinflammatory activities of pine (Pinus densiflora) pollen extract,” Phytother. Res., 21, No. 5, 471-475 (2007).PubMedCrossRefGoogle Scholar
  14. 14.
    S. R. Mada, M. R. Metukuri, L. Burugula, et al., “Antiinflammatory and antinociceptive activities of gossypin and procumbentin–cyclooxygenase-2 (COX-2) inhibition studies,” Phytother. Res., 23, No. 6, 878-884 (2009).PubMedCrossRefGoogle Scholar
  15. 15.
    S. McCabe, “Complimentary herbal and alternative drugs in clinical practice,” Perspect. Psychiatr. Care, 38, No. 3, 98-107 (2002).PubMedCrossRefGoogle Scholar
  16. 16.
    P. Morazzoni and E. Bombardelli, “Valeriana offcinalis: traditional use and recent evaluation of activity,” Fitoterapia, 66, 99-112 (1995).Google Scholar
  17. 17.
    R. Della Loggia, A. Tubaro, and C. Redaelli, “Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them,” Riv. Neurol., 51, 297-310 (1981).PubMedGoogle Scholar
  18. 18.
    D. Kennedy, W. Little, C. Haskell, and A. Scholey, “Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress,” Phytother. Res., 20, 96-102 (2006).PubMedCrossRefGoogle Scholar
  19. 19.
    I. Oliva, M. Gonzalez-Trujano, J. Arrieta, et al., “Neuropharmacological profile of hydroalcohol extract of Valeriana edulis ssp. procera roots in mice,” Phytother. Res., 18, 290-296 (2004).PubMedCrossRefGoogle Scholar
  20. 20.
    E. Abourashed, U. Koetter, and A. Brattstrom, “In vitro binding experiments with Valerian hops, and their fixed combination extract (Ze91019) to selected central nervous system receptors,” Phytomedicine, 11, 633-638 (2004).PubMedCrossRefGoogle Scholar
  21. 21.
    C. Nencini, F. Cavallo, A. Capasso, et al., “Binding studies for serotoninergic, dopaminergic, and noradrenergic receptors of Valeriana adscendens Trel. extracts,” J. Ethnopharmacol., 108, No. 2, 185-187 (2006).PubMedCrossRefGoogle Scholar
  22. 22.
    C. Wasowski, M. Marder, H. Viola, et al., “Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii D.C.,” Planta Med., 68, 934-936 (2002).PubMedCrossRefGoogle Scholar
  23. 23.
    U. Bodesheim and J. Hölzl, “Isolierung, Strukturaufklärung und Radioreceptorassays von Alkaloiden und Lignan aus Valeriana officinalis L.,” Pharmazie, 52, No., 386-391 (1997).PubMedGoogle Scholar
  24. 24.
    L. Bardin, J. P. Tarayre, N. Malfetes, et al., “Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain,” Pharmacology, 67, 182-194 (2003).PubMedCrossRefGoogle Scholar
  25. 25.
    F. C. Colpaert, J. P. Tarayre, W. Koek, et al., “Largeamplitude 5-HT1A receptor activation: a new mechanism of profound central analgesia,” Neuropharmacology, 43, No., 945-958 (2002).PubMedCrossRefGoogle Scholar
  26. 26.
    S. Fernandez, C. Wasowski, A. C. Paladini, and M. Marder, “Sedative and sleep-enhancing properties of linarin, a flavonoid isolated from Valeriana officinalis,” Pharmacol. Biochem. Behav., 77, No. 2, 399-404 (2004).PubMedCrossRefGoogle Scholar
  27. 27.
    S. L. Guzmán-Gutiérrez, and A. Navarrete, “Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers,” Planta Med., No. 75, 295-301 (2009).Google Scholar
  28. 28.
    A. L. Martinez, M. E. González-Trujano, M. Chávez, et al., “Hesperidin produces antinociceptive response and synergistic interaction with ketorolac in an arthritic gout-type pain in rats,” Pharmacol. Biochem. Behav., 97, No. 4, 683-689 (2010).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Neurophysiology Research CenterHamadan University of Medical SciencesHamadanIran
  2. 2.School of MedicineHamadan University of Medical SciencesHamadanIran

Personalised recommendations